Skip to main content
. 2019 Mar;25(3):10.18553/jmcp.2019.25.3.304. doi: 10.18553/jmcp.2019.25.3.304

TABLE 3.

Logistic Regression Predicting Odds of Experiencing Clinical Inertia in the Overall Unmatched Cohort (N = 3,078)

Variables Odds Ratio 95% CI P Valuea
Clinical inertia(ref: treatment intensification) - - -
Baseline age category, years (ref: < 50 years) - - -
  50-54 years 1.16 (0.92-1.47) 0.211
  55-59 years 1.20 (0.96-1.50) 0.113
  60-64 years 1.08 (0.86-1.37) 0.511
  ≥ 65 years 2.11 (1.63-2.74) < 0.001
Male (ref: female) 1.01 (0.86-1.19) 0.902
Race (ref: white) - - -
  Nonwhite 1.32 (0.94-1.84) 0.105
  Missing 0.99 (0.75-1.31) 0.953
Baseline A1c ≥ 9.0%(Ref: A1c ≥ 8.0% to < 9.0%) 0.56 (0.48-0.66) < 0.001
Baseline number of antihyperglycemic medications (ref: 0) - - -
  1 0.75 (0.61-0.91) 0.004
  2 1.51 (1.22-1.86) <0.001
  ≥ 3 1.78 (1.30-2.42) <0.001
Receiving diabetic counseling at baseline 0.91 (0.66-1.24) 0.547
Baseline comorbidities - - -
  Anxiety 0.95 (0.72-1.26) 0.733
  Depression 1.10 (0.86-1.39) 0.451
  Severe mental illness 1.11 (0.81-1.50) 0.516
  Hypertension 1.09 (0.92-1.30) 0.326
  Dyslipidemia 1.03 (0.86-1.22) 0.766
  Obesity 0.81 (0.65-1.00) 0.054
  Coronary heart disease 1.44 (1.10-1.88) 0.007
  Chronic kidney disease 0.99 (0.64-1.51) 0.953
  Nephropathy 1.47 (0.87-2.48) 0.150
  Neuropathy 1.00 (0.66-1.50) 0.993
  Retinopathy 1.20 (0.73-1.96) 0.464

aP values for statistical significance were obtained from the logistic regression model; bolded P values indicate statistical significance.

A1c = hemoglobin A1c; CI = confidence interval; ref = reference.